Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-25-000486
Filing Date
2025-01-02
Accepted
2025-01-02 16:32:44
Documents
15
Effectiveness Date
2025-01-02

Document Format Files

Seq Description Document Type Size
1 S-8 nktx-20250102.htm S-8 158117
2 EX-5 nktx-ex5.htm EX-5 9767
3 EX-23.1 nktx-ex23_1.htm EX-23.1 3616
4 EX-FILING FEES nktx_exfilingfees.htm   iXBRL EX-FILING FEES 40871
  Complete submission text file 0000950170-25-000486.txt   368700

Data Files

Seq Description Document Type Size
17 EXTRACTED XBRL INSTANCE DOCUMENT nktx_exfilingfees_htm.xml XML 16979
Mailing Address 1150 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1150 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080 (925) 407-1049
Nkarta, Inc. (Filer) CIK: 0001787400 (see all company filings)

EIN.: 474515206 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-284111 | Film No.: 25502512
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)